Clinicopathological Prognostic Factors After Hepatectomy for Patients with Mass-Forming Type Intrahepatic Cholangiocarcinoma: Relevance of the Lymphatic Invasion Index

被引:47
|
作者
Shirabe, Ken [1 ]
Mano, Yohei [2 ]
Taketomi, Akinobu [1 ]
Soejima, Yuji [1 ]
Uchiyama, Hideaki [1 ]
Aishima, Shinichi [2 ]
Kayashima, Hiroto [1 ]
Ninomiya, Mizuki [1 ]
Maehara, Yoshihiko [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 812, Japan
关键词
LONG-TERM SURVIVAL; PHASE-II TRIAL; SURGICAL-TREATMENT; CISPLATIN GFP; GEMCITABINE; RESECTION; 5-FLUOROURACIL; MULTICENTER; CANCERS;
D O I
10.1245/s10434-010-0929-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study was conducted to clarify the pathological factors in patients who underwent surgery for mass-forming type intrahepatic cholangiocarcinoma (IHC). From 1982 to July 2004, a total of 60 liver resections for mass-forming type IHC were performed at Kyushu University and its affiliated institutions. Portal venous, lymphatic, hepatic venous, and serosal invasion was examined by univariate and multivariate analyses for their prognostic value. The portal venous (PV) invasion index was defined as follows: PV0, portal venous invasion (-) and intrahepatic metastasis (-); PV1, portal venous invasion (+) or intrahepatic metastasis (+); PV2, portal venous invasion (+) and intrahepatic metastasis (+). The lymphatic invasion (LI) index was defined as follows: LI0, lymphatic duct invasion (-) and lymph node metastasis (-); LI1, intrahepatic lymphatic duct invasion (+) or lymph node metastasis (+); LI2, intrahepatic lymphatic duct invasion (+) and lymph node metastasis (+). In univariate analysis, statistically significant prognostic factors for poor outcome were tumor size (> 5 cm), serosal invasion (+), PV1 or PV2, LI1 or LI2, histological grade (moderate and poor), hepatic venous invasion (+) and noncurative resection. After multivariate analysis, the lymphatic invasion index and histological grade were statistically independent prognostic factors for overall survival and recurrence-free survival. In patients with mass-forming type IHC, lymphatic invasion is the most important invasion pathway, compared with serosal and portal and hepatic venous invasion. Stratification of the lymphatic invasion pathway by lymphatic invasion, including intrahepatic lymphatic duct invasion and lymph node metastasis, is a good predictor for prognosis in patients after hepatectomy for mass-forming type IHC.
引用
收藏
页码:1816 / 1822
页数:7
相关论文
共 50 条
  • [1] Clinicopathological Prognostic Factors After Hepatectomy for Patients with Mass-Forming Type Intrahepatic Cholangiocarcinoma: Relevance of the Lymphatic Invasion Index
    Ken Shirabe
    Yohei Mano
    Akinobu Taketomi
    Yuji Soejima
    Hideaki Uchiyama
    Shinichi Aishima
    Hiroto Kayashima
    Mizuki Ninomiya
    Yoshihiko Maehara
    [J]. Annals of Surgical Oncology, 2010, 17 : 1816 - 1822
  • [2] Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma
    Shohachi Suzuki
    Takanori Sakaguchi
    Yoshihiro Yokoi
    Kazuya Okamoto
    Kiyotaka Kurachi
    Yasuo Tsuchiya
    Takuya Okumura
    Hiroyuki Konno
    Satoshi Baba
    Satoshi Nakamura
    [J]. World Journal of Surgery, 2002, 26 : 687 - 693
  • [3] Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma
    Suzuki, S
    Sakaguchi, T
    Yokoi, Y
    Okamoto, K
    Kurachi, K
    Tsuchiya, Y
    Okumura, T
    Konno, H
    Baba, S
    Nakamura, S
    [J]. WORLD JOURNAL OF SURGERY, 2002, 26 (06) : 687 - 693
  • [4] Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma
    Uenishi, T
    Hirohashi, K
    Kubo, S
    Yamamoto, T
    Yamazaki, O
    Kinoshita, H
    [J]. BRITISH JOURNAL OF SURGERY, 2001, 88 (07) : 969 - 974
  • [5] Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy
    Yeh, Chun-Nan
    Pang, See-Tong
    Wu, Ren-Ching
    Chen, Tsung-Wen
    Jan, Yi-Yin
    Chen, Miin-Fu
    [J]. ONCOLOGY REPORTS, 2009, 21 (01) : 49 - 56
  • [6] Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients
    Feng, Jian
    Liang, Bin
    Zhang, Hang-Yu
    Liu, Zhe
    Jiang, Kai
    Zhao, Xiang-Qian
    [J]. WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 14 (05): : 442 - 451
  • [7] CLINICOPATHOLOGICAL SPECTRUM OF RESECTED EXTRADUCTAL MASS-FORMING INTRAHEPATIC CHOLANGIOCARCINOMA
    YAMANAKA, N
    OKAMOTO, E
    ANDO, T
    ORIYAMA, T
    FUJIMOTO, J
    FURUKAWA, K
    TANAKA, T
    TANAKA, W
    NISHIGAMI, T
    [J]. CANCER, 1995, 76 (12) : 2449 - 2456
  • [8] Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy
    Abe, T.
    Amano, H.
    Shimamoto, F.
    Hattori, M.
    Kuroda, S.
    Kobayashi, T.
    Tashiro, H.
    Ohdan, H.
    [J]. EJSO, 2015, 41 (11): : 1515 - 1521
  • [9] Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma
    Uenishi, T
    Yamazaki, O
    Yamamoto, T
    Hirohashi, K
    Tanaka, H
    Tanaka, S
    Hai, S
    Kubo, S
    [J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2005, 12 (06): : 479 - 483
  • [10] Clinical characteristics and prognostic determinants of mass-forming intrahepatic cholangiocarcinoma
    Suzuki, S
    Nakamura, S
    Sakaguchi, T
    Kojima, Y
    Tsuchiya, Y
    Konno, H
    [J]. HEPATOLOGY, 1998, 28 (04) : 765A - 765A